A significant number of in vitro and in vivo pre-clinical studies can now be cited to support the importance of CXCL8-CXCR1/2 signaling in promoting tumor progression, via promotion of multiple hallmarks of cancer. The gene discussed is CXCR1; the disease is cancer.